LSD1 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tranylcypromine | 13492-01-8 | sc-200572 sc-200572A | 1 g 5 g | $172.00 $587.00 | 5 | |
Tranylcypromine exhibits remarkable reactivity as a chemical entity, particularly through its ability to form stable adducts with nucleophiles. Its unique structural features facilitate selective interactions with specific functional groups, influencing reaction pathways. The compound's kinetic behavior is characterized by rapid formation of intermediates, which can lead to diverse reaction outcomes. Additionally, Tranylcypromine's solvation dynamics play a crucial role in modulating its reactivity in different environments. | ||||||
trans 2-Phenylcyclopropylamine Hydrochloride | 1986-47-6 | sc-208452 sc-208452A | 250 mg 1 g | $56.00 $163.00 | 1 | |
Trans 2-Phenylcyclopropylamine Hydrochloride demonstrates intriguing properties as a potent LSD1 inhibitor, characterized by its ability to engage in specific hydrogen bonding interactions with the enzyme's active site. This compound's unique cyclopropyl structure enhances its conformational flexibility, allowing for effective binding and modulation of enzymatic activity. Its distinct electronic properties contribute to selective reactivity, influencing the kinetics of substrate interactions and downstream signaling pathways. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
SP2509 functions as a potent LSD1 inhibitor, characterized by its ability to engage in specific hydrogen bonding with critical amino acids within the enzyme's active site. This interaction not only stabilizes the enzyme-inhibitor complex but also alters the conformational dynamics of LSD1, leading to a unique modulation of its enzymatic activity. The compound's distinct steric properties further enhance its selectivity, influencing downstream signaling pathways and cellular responses. | ||||||
RN 1 dihydrochloride | 1781835-13-9 | sc-397054 | 10 mg | $205.00 | ||
RN 1 dihydrochloride exhibits remarkable characteristics as an LSD1 inhibitor, primarily through its ability to form stable electrostatic interactions with key residues in the enzyme's active site. The compound's unique structural features facilitate a dynamic binding mode, promoting enhanced affinity and selectivity. Additionally, its hydrophilic nature influences solubility and distribution, impacting the overall reaction kinetics and the modulation of associated biochemical pathways. | ||||||
GSK LSD1 Dihydrochloride | 1431368-48-7 (free base) | sc-490345 | 5 mg | $90.00 | 4 | |
GSK LSD1 Dihydrochloride acts as a selective inhibitor of LSD1, showcasing a unique ability to disrupt the enzyme's catalytic mechanism through competitive binding. Its structural features facilitate specific interactions with the enzyme's substrate-binding pocket, leading to altered reaction kinetics. The compound's hydrophilic nature enhances solubility, promoting effective diffusion within cellular environments, while its distinct electronic properties influence the overall stability of the enzyme-inhibitor complex. | ||||||
OG-L002 | 1357302-64-7 | sc-478221 | 5 mg | $270.00 | ||
OG-L002 functions as a selective LSD1 inhibitor, characterized by its unique ability to modulate histone methylation dynamics. Its molecular architecture allows for precise interactions with the enzyme's active site, effectively altering substrate affinity and reaction rates. The compound's distinctive steric properties contribute to its binding efficacy, while its polar functional groups enhance solvation, facilitating its interaction with cellular components and influencing downstream signaling pathways. | ||||||